Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

<< Previous

Bullboard Posts

Next >>

Post by lonc17on Jun 23, 2023 5:03pm

235 Views

Post# 35512136

ATM

Today's volume strongly suggests that ONC is diluting big-time through the ATM.

Understandalbe, I guess. They have a burn rate of close to $1 million per month just to pay the c-suite salaries.

I long for the day when this is bought out by big pharma and MC rides off into the sunset.

PanCAN picked ONC. Pelareorep is has the biggest potential in pancreatic cancer at this moment.

Big Pharma bidding war on the way soon.

MC should let the SP ride up nicely without ATM interference!

<< Previous

Bullboard Posts

Next >>

How a world class helium discovery in Minnesota was made by chance